BCWorldPharm Co (200780.KQ) Stock Price

BCWorldPharm Co Price

CLOSED
2,850.00
​
Market closed

Revenue has compounded at 8.7% per year over the past 13 years to 75.80 B KRW. Earnings per share have declined at 5.9% per year over the last 11 years. BCWorldPharm Co's net margin stands at -6.5%, down from -3.0% several years earlier. BCWorldPharm Co currently offers a dividend yield of about 3.51%. The dividend has grown at 4.4% per year over the past 11 years.

BCWorldPharm Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BCWorldPharm Co business model & stock analysis

BCWorldPharm Co Ltd generates revenue through the manufacturing and development of pharmaceutical products. The company produces anesthetic pain medications including cancer pain treatment, muscle relaxants, and anesthesia and pain relief drugs. It also develops circulation contracts for hypertension and hyperlipidemia, antibiotics for tuberculosis treatment, and other prescription drugs such as peptic ulcer and osteoporosis medications. BCWorldPharm focuses on improved drugs and new product development to meet market demands. The primary buyers of BCWorldPharm's products are healthcare providers and hospitals requiring pharmaceutical solutions for various medical conditions. These include oncology departments for cancer pain treatment, cardiology units for hypertension and hyperlipidemia management, and infectious disease specialists for tuberculosis treatment. The company targets specific medical segments through its specialized drug portfolio. BCWorldPharm's product portfolio includes prescription drugs categorized by therapeutic area, such as anesthetic pain medications, circulation contracts, antibiotics, and other prescription drugs. The company's development focus on improved drugs and new products ensures continuous market relevance and growth within the pharmaceutical sector.

Frequently asked questions about BCWorldPharm Co

Converted at the current exchange rate, the BCWorldPharm Co share trades at 1.94 EUR (2,850.00 KRW).

The revenue cannot currently be calculated for BCWorldPharm Co.

The profit cannot currently be calculated for BCWorldPharm Co.

The P/E ratio cannot be calculated for BCWorldPharm Co at the moment.

The P/S cannot be calculated for BCWorldPharm Co currently.

The Eulerpool Quality Score for BCWorldPharm Co is 1/10.

The ISIN of BCWorldPharm Co is KR7200780005. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of BCWorldPharm Co is 200780.KQ. The ticker symbol is used to trade BCWorldPharm Co shares on the stock exchange.

Fair ValueTerminal
2,907.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bcwp.co.kr
Country
South Korea
Currency
KRW
Initial public offering
Dec 15, 2014
ISIN
KR7200780005
Cusip
Y0R7W4105
Market capitalization
29.10 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
18.64
P/B Ratio
0.41
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.74 %
Dividend
Dividend yield
3.51 %
Payout Ratio
-24.03 %
Dividend growth Ø5Y
3.89 %
Dividend payments per year
1
Dividend paid since
10 years
Dividend not reduced since
10 years
Dividend increased since
2 years
Dividend withholding tax
22.00 %
Last updated Nov 17, 2026, 3:48 AM

BCWorldPharm Co Peer Group

BCWorldPharm Co FIGI

200780:KS · BBG001BNGVP1200780:KQ · BBG007GGTWG2